23,558 Shares in Option Care Health, Inc. $OPCH Acquired by Brookstone Capital Management

Brookstone Capital Management purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 23,558 shares of the company’s stock, valued at approximately $634,000.

Several other institutional investors have also recently added to or reduced their stakes in OPCH. V Square Quantitative Management LLC bought a new position in Option Care Health in the 4th quarter valued at $25,000. McIlrath & Eck LLC bought a new position in shares of Option Care Health during the 2nd quarter valued at about $37,000. Advisory Services Network LLC acquired a new position in Option Care Health in the 3rd quarter worth $35,000. Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health during the 3rd quarter worth approximately $38,000. Finally, Employees Retirement System of Texas acquired a new position in shares of Option Care Health during the 4th quarter worth about $45,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of OPCH stock opened at $21.82 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The company has a market cap of $3.43 billion, a P/E ratio of 16.91, a P/E/G ratio of 1.21 and a beta of 0.67. The firm has a 50-day moving average of $22.38 and a 200-day moving average of $28.65. Option Care Health, Inc. has a one year low of $18.01 and a one year high of $36.80.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s revenue was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts forecast that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on OPCH shares. Zacks Research downgraded Option Care Health from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Weiss Ratings lowered shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $26.00 price target on shares of Option Care Health in a report on Friday, May 1st. Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a research note on Wednesday, May 6th. Finally, UBS Group restated a “buy” rating on shares of Option Care Health in a research report on Tuesday, June 16th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $30.54.

Insider Buying and Selling

In other news, CEO John Charles Rademacher acquired 12,500 shares of Option Care Health stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was purchased at an average cost of $21.41 per share, with a total value of $783,820.10. Following the completion of the transaction, the director directly owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. The trade was a 8.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have purchased 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is owned by company insiders.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.